Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 582
Filtrar
1.
World J Microbiol Biotechnol ; 40(10): 314, 2024 Sep 09.
Artigo em Inglês | MEDLINE | ID: mdl-39249571

RESUMO

This research propounds an innovative technology focused on sustainability to increase the biomass yield of Akkermansia muciniphila, the next-generation probiotic, using prebiotic sources to replace or reduce animal mucin levels. A series of experimental design approaches were developed aiming to optimize the growth of Akkermansiamuciniphila by incorporating extracts of green leafy vegetables and edible mushroom into the cultivation media. Experiments using kale extract (KE), Brassica oleracea L., associated with lyophilized mushroom extract (LME) of Pleurotus ostreatus were the most promising, highlighting the assays with 0.376% KE and 0.423% LME or 1.05% KE and 0.5% LME, in which 3.5 × 1010 CFU (Colony Forming Units) mL- 1 was achieved - higher than in experiments in optimized synthetic media. Such results enhance the potential of using KE and LME not only as mucin substitutes, but also as a source to increase Akkermansia muciniphila biomass yields and release short-chain fatty acids. The work is relevant to the food and pharmaceutical industries in the preparation of the probiotic ingredient.


Assuntos
Akkermansia , Biomassa , Meios de Cultura , Prebióticos , Probióticos , Verrucomicrobia , Akkermansia/crescimento & desenvolvimento , Meios de Cultura/química , Verrucomicrobia/crescimento & desenvolvimento , Verrucomicrobia/metabolismo , Pleurotus/crescimento & desenvolvimento , Pleurotus/metabolismo , Ácidos Graxos Voláteis/metabolismo , Extratos Vegetais/química , Brassica/crescimento & desenvolvimento , Brassica/microbiologia
2.
Microbiologyopen ; 13(4): e1430, 2024 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-39115291

RESUMO

The gut microbiota significantly contributes to human health and well-being. The aim of this study was to evaluate the stability and resilience of a consortium composed of three next-generation probiotics (NGPs) candidates originally found in the human gut. The growth patterns of Akkermansia muciniphila, Bacteroides thetaiotaomicron, and Faecalibacterium prausnitzii were studied both individually and consortium. The growth kinetics of Akkermansia muciniphila (A. muciniphila), Bacteroides thetaiotaomicron (B. thetaiotaomicron), and Faecalibacterium prausnitzii (F. prausnitzii) were characterized both individually and in consortium using isothermal microcalorimetry and 16S ribosomal RNA next-generation sequencing. The consortium reached stability after three passages and demonstrated resilience to changes in its initial composition. The concentration of butyrate produced was nearly twice as high in the consortium compared to the monoculture of F. prausnitzii. The experimental conditions and methodologies used in this article are a solid foundation for developing further complex consortia.


Assuntos
Calorimetria , Microbioma Gastrointestinal , RNA Ribossômico 16S , Humanos , Microbioma Gastrointestinal/fisiologia , RNA Ribossômico 16S/genética , Faecalibacterium prausnitzii/genética , Akkermansia/crescimento & desenvolvimento , Akkermansia/fisiologia , Consórcios Microbianos/fisiologia , Consórcios Microbianos/genética , Sequenciamento de Nucleotídeos em Larga Escala , Butiratos/metabolismo , Probióticos , Verrucomicrobia/genética , Verrucomicrobia/crescimento & desenvolvimento , Bacteroides/genética , Bacteroides/crescimento & desenvolvimento , DNA Bacteriano/genética
3.
Chem Commun (Camb) ; 60(68): 9089-9092, 2024 Aug 20.
Artigo em Inglês | MEDLINE | ID: mdl-39108142

RESUMO

Herein, we have developed a non-enzymatic, isothermal amplification assay (NIA sensor) based on a catalytic hairpin assembly (CHA) reaction for quantifying the relative abundance of Akkermansia muciniphila. Through detection of the MUC-1437 gene (limit of detection: 8.3 fM) in a dynamic range from 10 fM to 1 nM, the NIA sensor shows high sensitivity and selectivity in preclinical models of mice fed a normal or high-fat diet (HFD), and treated with antibiotics (ATB). The NIA sensor, which operates without the use of any enzymes, leading to simplicity and cost-effectiveness, has great potential for biosensing research and clinical diagnostic applications.


Assuntos
Akkermansia , Técnicas de Amplificação de Ácido Nucleico , Animais , Camundongos , Técnicas Biossensoriais , Antibacterianos/farmacologia , Dieta Hiperlipídica , Limite de Detecção , Verrucomicrobia/genética , Verrucomicrobia/isolamento & purificação
4.
J Neuroimmune Pharmacol ; 19(1): 43, 2024 Aug 14.
Artigo em Inglês | MEDLINE | ID: mdl-39141019

RESUMO

Recent studies have demonstrated the interaction between gut microbiota and brain on ischemic stroke, but the roles of gut microbiota in the pathophysiology of ischemic stroke remain largely unclear. In this study, we detected a significant increase of intestinal Akkermansia muciniphila (AKK) following ischemic stroke by a rose bengal photothrombosis model. To investigate the function and mechanism of AKK on ischemic stroke, we performed the AKK administration prior to stroke surgery. The results showed that mice treated with AKK gained significantly higher body weight and behaved better than those in PBS group at 3 days after ischemic stroke. Consistently, AKK administration remarkably decreased the infarct volumes as well as the density of degenerating neurons and apoptotic cells after ischemic stroke. Notably, AKK is a potential therapeutic target in immune-related disorders connected to the microbiota, and inflammation is crucially involved in the pathophysiological process of ischemic stroke. For the determination of underlying mechanisms of this protective effect, we investigated whether there are associations between AKK and neuroinflammation following ischemic stroke. The results suggested that AKK administration significantly reduced the activation of astrocytes and microglia but up-regulated multiple anti-inflammatory factors following ischemic stroke. Therefore, our study highlighted the beneficial roles of intestinal AKK on ischemic stroke and provided a new perspective for the treatment of ischemic stroke.


Assuntos
Akkermansia , Microbioma Gastrointestinal , AVC Isquêmico , Recuperação de Função Fisiológica , Animais , Masculino , Camundongos , Microbioma Gastrointestinal/fisiologia , Camundongos Endogâmicos C57BL , Recuperação de Função Fisiológica/fisiologia , Verrucomicrobia
5.
Virulence ; 15(1): 2375555, 2024 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-39192579

RESUMO

Metabolic disease is a worldwide epidemic that has become a public health problem. Gut microbiota is considered to be one of the important factors that maintain human health by regulating host metabolism. As an abundant bacterium in the host gut, A. muciniphila regulates metabolic and immune functions, and protects gut health. Multiple studies have indicated that alterations in the abundance of A. muciniphila are associated with various diseases, including intestinal inflammatory diseases, obesity, type 2 diabetes mellitus, and even parasitic diseases. Beneficial effects were observed not only in live A. muciniphila, but also in pasteurized A. muciniphila, A. muciniphila-derived extracellular vesicles, outer membrane, and secreted proteins. Although numerous studies have only proven the simple correlation between multiple diseases and A. muciniphila, an increasing number of studies in animal models and preclinical models have demonstrated that the beneficial impacts shifted from correlations to in-depth mechanisms. In this review, we provide a comprehensive view of the beneficial effects of A. muciniphila on different diseases and summarize the potential mechanisms of action of A. muciniphila in the treatment of diseases. We provide a comprehensive understanding of A. muciniphila for improving host health and discuss the perspectives of A. muciniphila in the future studies.


Assuntos
Akkermansia , Microbioma Gastrointestinal , Inflamação , Doenças Metabólicas , Probióticos , Probióticos/uso terapêutico , Humanos , Animais , Doenças Metabólicas/microbiologia , Doenças Metabólicas/prevenção & controle , Doenças Metabólicas/terapia , Diabetes Mellitus Tipo 2/microbiologia , Diabetes Mellitus Tipo 2/imunologia , Obesidade/microbiologia , Verrucomicrobia
7.
Future Microbiol ; 19(12): 1081-1096, 2024 Aug 12.
Artigo em Inglês | MEDLINE | ID: mdl-39109507

RESUMO

Akkermansia muciniphila (A. muciniphila) is a 'star strain' that has attracted much attention in recent years. A. muciniphila can effectively regulate host metabolism, significantly affect host immune function, and play an important role in balancing host health and disease. As one of the organs most closely related to the gut (the two can communicate through the hepatic portal vein and bile duct system), liver is widely affected by intestinal microorganisms. A growing body of evidence suggests that A. muciniphila may alleviate liver-related diseases by improving the intestinal barrier, energy metabolism and regulating inflammation through its protein components and metabolites. This paper systematically reviews the key roles of A. muciniphila and its derivatives in maintaining liver health and improving liver disease.


[Box: see text].


Assuntos
Akkermansia , Microbioma Gastrointestinal , Fígado , Humanos , Akkermansia/fisiologia , Fígado/microbiologia , Fígado/metabolismo , Microbioma Gastrointestinal/fisiologia , Animais , Hepatopatias/microbiologia , Verrucomicrobia/fisiologia , Probióticos
8.
Sci Rep ; 14(1): 20056, 2024 08 29.
Artigo em Inglês | MEDLINE | ID: mdl-39209875

RESUMO

Although Akkermansia muciniphila (Am) plays a beneficial role as a probiotic in the treatment of metabolic syndrome, the mechanisms remain elusive. We tested the hypothesis that Am extracellular vesicles (AmEVs) protect against hypertension through modulation of gene expression in the kidneys of spontaneously hypertensive rats (SHRs). Extracellular vesicles purified from anaerobically cultured Am (1.0 × 108 or 1.0 × 109 particles/kg) or vehicles were injected into the tail veins of Wistar-Kyoto rats (WKYs) and SHRs weekly for 4 weeks. Renal cortical tissues isolated from both rat strains were analyzed by trichrome stain and RT-qPCR. AmEVs protect against the development of hypertension in SHRs without a serious adverse reaction. AmEVs increased the expression of vasocontracting Agt and At1ar as well as vasodilating At2r, Mas1 and Nos2 in the kidneys of both strains. These results indicate that AmEVs have a protective effect against hypertension without a serious adverse reaction. Therefore, it is foreseen that AmEVs may be utilized as a novel therapeutic for the treatment of hypertension.


Assuntos
Akkermansia , Vesículas Extracelulares , Hipertensão , Rim , Ratos Endogâmicos SHR , Ratos Endogâmicos WKY , Animais , Vesículas Extracelulares/metabolismo , Ratos , Rim/metabolismo , Hipertensão/metabolismo , Hipertensão/genética , Masculino , Administração Intravenosa , Verrucomicrobia/genética , Regulação da Expressão Gênica , Probióticos/administração & dosagem
9.
Phytomedicine ; 132: 155888, 2024 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-39084128

RESUMO

BACKGROUND: The efficacy of Liangxue Guyuan Yishen Decoction (LGYD), a traditional Chinese medicine, has been scientifically proven in the treatment of radiation-induced intestinal injury (RIII) and preservation of intestinal integrity and function following high-dose radiation exposure. However, further investigation is required to comprehensively elucidate the precise mechanisms underlying the therapeutic effects of LGYD in order to provide potential pharmaceutical options for radiation protection. PURPOSE: This study aims to elucidate the potential mechanism through which LGYD exerts its therapeutic effects on RIII by modulating the gut microbiota (GM). METHODS: 16 s rRNA analysis was employed to assess the impact of varying doses of whole body irradiation (WBI) on GM in order to establish an appropriate model for this study. The effects of LGYD on GM and SCFA were evaluated using 16 s rRNA and Quantification of SCFA. UHPLC-QE-MS was utilized to identify the active components in LGYD as well as LGYD drug containing serum (LGYD-DS). Subsequently, immunofluorescence and immunohistochemical staining were conducted to validate the influence of LGYD and/or characteristic microbiota on RIII recovery in vivo. The effects of LGYD-DS, characteristic flora, and SCFA on intestinal stem cell (ISC) were assessed by measuring organoid surface area in intestinal organoid model. RESULTS: The species composition and abundance of GM were significantly influenced by whole-body irradiation with a dose of 8.5 Gy, which was used as in vivo model. LGYD significantly improves the survival rate and promotes recovery from RIII. Additionally, LGYD exhibited a notable increase in the abundance of Akkermansia muciniphila (AKK) and levels of SCFA, particularly isobutyric acid. LGYD-DS consisted of seven main components derived from herbs of LGYD. In vivo experiments indicated that both LGYD and AKK substantially enhanced the survival rate after radiation and facilitated the recovery process for intestinal structure and function. In the organoid model, treatment with LGYD-DS, AKK supernatant or isobutyric acid significantly increased organoid surface area. CONCLUSIONS: LGYD has the potential to enhance RIII by promoting the restoration of intestinal stem cell, which is closely associated with the upregulation of AKK abundance and production of SCFA, particularly isobutyric acid.


Assuntos
Medicamentos de Ervas Chinesas , Microbioma Gastrointestinal , Animais , Medicamentos de Ervas Chinesas/farmacologia , Microbioma Gastrointestinal/efeitos dos fármacos , Camundongos , Masculino , Células-Tronco/efeitos dos fármacos , Akkermansia/efeitos dos fármacos , Verrucomicrobia/efeitos dos fármacos , Intestinos/efeitos dos fármacos , Intestinos/microbiologia , Intestinos/efeitos da radiação , Irradiação Corporal Total , Camundongos Endogâmicos C57BL
10.
Phytomedicine ; 132: 155847, 2024 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-38996505

RESUMO

BACKGROUND: Gut microbiota dysbiosis significantly contributes to progression of depression. Hypericum perforatum L. (HPL) is traditionally used in Europe for treating depression. However, its mechanism remains largely underexplored. PURPOSE: This study aims to investigate the pivotal gut microbiota species and microbial signaling metabolites associated with the antidepressant effects of HPL. METHODS: Fecal microbiota transplantation was used to assess whether HPL mitigates depression through alterations in gut microbiota. Microbiota and metabolic profiling of control, chronic restraint stress (CRS)-induced depression, and HPL-treated CRS mice were examined using 16S rRNA gene sequencing and metabolomics analysis. The influence of gut microbiota on HPL's antidepressant effects was assessed by metabolite and bacterial intervention experiments. RESULTS: HPL significantly alleviated depression symptoms in a manner dependent on gut microbiota and restored gut microbial composition by enriching Akkermansia muciniphila (AKK). Metabolomic analysis indicated that HPL regulated tryptophan metabolism, reducing kynurenine (KYN) levels derived from microbiota and increasing 5-hydroxytryptophan (5-HTP) levels. Notably, supplementation with KYN activated the NFκB-NLRP2-Caspase1-IL1ß pathway and increased proinflammatory IL1ß in the hippocampus of mice with depression. Interestingly, mono-colonization with AKK notably increased 5-hydroxytryptamine (5-HT) and decreased KYN levels, ameliorating depression symptoms through modulation of the NFκB-NLRP2-Caspase1-IL1ß pathway. CONCLUSIONS: The promising therapeutic role of HPL in treating depression is primarily attributed to its regulation of the NFκB-NLRP2-Caspase1-IL1ß pathway, specifically by targeting AKK and tryptophan metabolites.


Assuntos
Akkermansia , Antidepressivos , Depressão , Microbioma Gastrointestinal , Hypericum , Interleucina-1beta , NF-kappa B , Triptofano , Animais , Hypericum/química , Microbioma Gastrointestinal/efeitos dos fármacos , Depressão/tratamento farmacológico , Triptofano/metabolismo , Triptofano/farmacologia , Masculino , NF-kappa B/metabolismo , Interleucina-1beta/metabolismo , Camundongos , Antidepressivos/farmacologia , Camundongos Endogâmicos C57BL , Caspase 1/metabolismo , Transplante de Microbiota Fecal , Verrucomicrobia , Extratos Vegetais/farmacologia , Transdução de Sinais/efeitos dos fármacos , Disbiose/tratamento farmacológico , Disbiose/microbiologia , Modelos Animais de Doenças
11.
Front Cell Infect Microbiol ; 14: 1367998, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-39027140

RESUMO

Introduction: Ulcerative colitis is an inflammatory disorder characterized by chronic inflammation in the gastrointestinal tract, mainly in the colon and rectum. Although the precise etiology of ulcerative colitis remains unclear, recent research has underscored the significant role of the microbiome in its development and progression. Methods: The aim of this study was to establish a relationship between the levels of specific gut bacterial species and disease relapse in ulcerative colitis. For this study, we recruited 105 ulcerative colitis patients in remission and collected clinical data, blood, and stool samples. Akkermansia muciniphila and Parabacteroides distasonis levels were quantified in the stool samples of ulcerative colitis patients. Binary logistic regression was applied to collected data to predict disease remission. Results: The median time in remission in this cohort was four years. A predictive model incorporating demographic information, clinical data, and the levels of Akkermansia muciniphila and Parabacteroides distasonis was developed to understand remission patterns. Discussion: Our findings revealed a negative correlation between the levels of these two microorganisms and the duration of remission. These findings highlight the importance of the gut microbiota in ulcerative colitis for disease prognosis and for personalized treatments based on microbiome interventions.


Assuntos
Akkermansia , Bacteroidetes , Colite Ulcerativa , Fezes , Microbioma Gastrointestinal , Recidiva , Humanos , Colite Ulcerativa/microbiologia , Feminino , Masculino , Adulto , Prognóstico , Pessoa de Meia-Idade , Bacteroidetes/isolamento & purificação , Fezes/microbiologia , Biomarcadores/sangue , Verrucomicrobia/isolamento & purificação , Adulto Jovem , Idoso
13.
Nutrients ; 16(11)2024 May 29.
Artigo em Inglês | MEDLINE | ID: mdl-38892628

RESUMO

This comprehensive review delineates the extensive roles of Akkermansia muciniphila in various health domains, spanning from metabolic and inflammatory diseases to neurodegenerative disorders. A. muciniphila, known for its ability to reside in the mucous layer of the intestine, plays a pivotal role in maintaining gut integrity and interacting with host metabolic processes. Its influence extends to modulating immune responses and potentially easing symptoms across several non-communicable diseases, including obesity, diabetes, inflammatory bowel disease, and cancer. Recent studies highlight its capacity to interact with the gut-brain axis, suggesting a possible impact on neuropsychiatric conditions. Despite the promising therapeutic potential of A. muciniphila highlighted in animal and preliminary human studies, challenges remain in its practical application due to stability and cultivation issues. However, the development of pasteurized forms and synthetic mediums offers new avenues for its use in clinical settings, as recognized by regulatory bodies like the European Food Safety Authority. This narrative review serves as a crucial resource for understanding the broad implications of A. muciniphila across different health conditions and its potential integration into therapeutic strategies.


Assuntos
Akkermansia , Microbioma Gastrointestinal , Doenças não Transmissíveis , Probióticos , Humanos , Microbioma Gastrointestinal/fisiologia , Probióticos/uso terapêutico , Animais , Doenças não Transmissíveis/prevenção & controle , Doenças não Transmissíveis/terapia , Doenças Inflamatórias Intestinais/microbiologia , Doenças Inflamatórias Intestinais/terapia , Verrucomicrobia , Eixo Encéfalo-Intestino/fisiologia , Obesidade/microbiologia , Obesidade/terapia , Neoplasias/terapia , Neoplasias/microbiologia , Diabetes Mellitus/terapia , Diabetes Mellitus/microbiologia
14.
Exp Neurol ; 378: 114823, 2024 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-38782351

RESUMO

The established role of disturbances in the microbiota-gut-brain axis in the development of diabetic cognitive impairment (DCI) has long been recognized. It has shown the potential of Akkermansia muciniphila (A. muciniphila) in improving metabolic disorders and exerting anti-inflammatory effects. However, there remains a lack of comprehensive understanding regarding the specific effects and mechanisms underlying the treatment of DCI with A. muciniphila. This study aimed to evaluate the potential of A. muciniphila in alleviating DCI in db/db mice. Eleven-week-old db/db mice were administered either live or pasteurized A. muciniphila (5 × 109 CFU/200 µL) for a duration of eight weeks. Administering live A. muciniphila significantly ameliorated cognitive impairments, improved the synaptic ultrastructure, and inhibited hippocampal neuron loss in the CA1 and CA3 subregions in db/db mice. Both live and pasteurized A. muciniphila effectively mitigated neuroinflammation. Moreover, live A. muciniphila increased the relative abundance of Lactococcus and Staphylococcus, whereas pasteurized A. muciniphila increased the relative abundance of Lactobacillus, Prevotellaceae_UCG_001, and Alistipes. Supplementation of A. muciniphila also induced alterations in serum and brain metabolites, with a particular enrichment observed in tryptophan metabolism, glyoxylate and dicarboxylate metabolism, nitrogen metabolism, and pentose and glucuronate interconversions. Correlation analysis further demonstrated a direct and substantial correlation between the altered gut microbiota and the metabolites in the serum and brain tissue. In conclusion, the results indicate that live A. muciniphila demonstrated greater efficacy compared to pasteurized A. muciniphila. The observed protective effects of A. muciniphila against DCI are likely mediated through the neuroinflammation and microbiota-metabolites-brain axis.


Assuntos
Akkermansia , Disfunção Cognitiva , Microbioma Gastrointestinal , Probióticos , Animais , Microbioma Gastrointestinal/fisiologia , Camundongos , Disfunção Cognitiva/metabolismo , Disfunção Cognitiva/dietoterapia , Disfunção Cognitiva/etiologia , Masculino , Probióticos/farmacologia , Probióticos/uso terapêutico , Verrucomicrobia , Camundongos Endogâmicos C57BL , Pasteurização
15.
Cell ; 187(11): 2687-2689, 2024 May 23.
Artigo em Inglês | MEDLINE | ID: mdl-38788691

RESUMO

In this issue of Cell, Nie and co-authors report that the microbe-derived bile acid (BA) 3-succinylated cholic acid protects against the progression of metabolic dysfunction-associated liver disease. Intriguingly, its protective mechanism does not involve traditional BA signaling pathways but is instead linked to the proliferation of the commensal microbe Akkermansia muciniphila.


Assuntos
Akkermansia , Ácidos e Sais Biliares , Publicações Periódicas como Assunto , Animais , Humanos , Camundongos , Akkermansia/metabolismo , Ácidos e Sais Biliares/metabolismo , Ácido Cólico/metabolismo , Microbioma Gastrointestinal , Fígado/metabolismo , Hepatopatias/metabolismo , Hepatopatias/microbiologia , Verrucomicrobia/metabolismo
16.
Nat Commun ; 15(1): 4582, 2024 May 29.
Artigo em Inglês | MEDLINE | ID: mdl-38811534

RESUMO

The intestinal anaerobic bacterium Akkermansia muciniphila is specialized in the degradation of mucins, which are heavily O-glycosylated proteins that constitute the major components of the mucus lining the intestine. Despite that adhesion to mucins is considered critical for the persistence of A. muciniphila in the human intestinal tract, our knowledge of how this intestinal symbiont recognizes and binds to mucins is still limited. Here, we first show that the mucin-binding properties of A. muciniphila are independent of environmental oxygen concentrations and not abolished by pasteurization. We then dissected the mucin-binding properties of pasteurized A. muciniphila by use of a recently developed cell-based mucin array that enables display of the tandem repeats of human mucins with distinct O-glycan patterns and structures. We found that A. muciniphila recognizes the unsialylated LacNAc (Galß1-4GlcNAcß1-R) disaccharide selectively on core2 and core3 O-glycans. This disaccharide epitope is abundantly found on human colonic mucins capped by sialic acids, and we demonstrated that endogenous A. muciniphila neuraminidase activity can uncover the epitope and promote binding. In summary, our study provides insights into the mucin-binding properties important for colonization of a key mucin-foraging bacterium.


Assuntos
Akkermansia , Mucinas , Polissacarídeos , Akkermansia/metabolismo , Humanos , Mucinas/metabolismo , Polissacarídeos/metabolismo , Neuraminidase/metabolismo , Ligação Proteica , Glicosilação , Dissacarídeos/metabolismo , Verrucomicrobia/metabolismo , Epitopos/metabolismo , Aderência Bacteriana
17.
Mol Syst Biol ; 20(6): 596-625, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38745106

RESUMO

The erosion of the colonic mucus layer by a dietary fiber-deprived gut microbiota results in heightened susceptibility to an attaching and effacing pathogen, Citrobacter rodentium. Nevertheless, the questions of whether and how specific mucolytic bacteria aid in the increased pathogen susceptibility remain unexplored. Here, we leverage a functionally characterized, 14-member synthetic human microbiota in gnotobiotic mice to deduce which bacteria and functions are responsible for the pathogen susceptibility. Using strain dropouts of mucolytic bacteria from the community, we show that Akkermansia muciniphila renders the host more vulnerable to the mucosal pathogen during fiber deprivation. However, the presence of A. muciniphila reduces pathogen load on a fiber-sufficient diet, highlighting the context-dependent beneficial effects of this mucin specialist. The enhanced pathogen susceptibility is not owing to altered host immune or pathogen responses, but is driven by a combination of increased mucus penetrability and altered activities of A. muciniphila and other community members. Our study provides novel insights into the mechanisms of how discrete functional responses of the same mucolytic bacterium either resist or enhance enteric pathogen susceptibility.


Assuntos
Akkermansia , Citrobacter rodentium , Microbioma Gastrointestinal , Animais , Camundongos , Citrobacter rodentium/patogenicidade , Humanos , Suscetibilidade a Doenças , Fibras na Dieta/metabolismo , Vida Livre de Germes , Dieta , Mucosa Intestinal/microbiologia , Mucosa Intestinal/metabolismo , Mucosa Intestinal/imunologia , Verrucomicrobia/genética , Infecções por Enterobacteriaceae/microbiologia , Colo/microbiologia , Camundongos Endogâmicos C57BL
18.
Gut Microbes ; 16(1): 2338947, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38717824

RESUMO

The gut microbiota has coevolved with the host for hundreds of millions of years, playing a beneficial role in host health. Human parasitic helminths are widespread and pose a pervasive global public health issue. Although Type 2 immunity provides partial resistance to helminth infections, the composition of the gut microbiota can change correspondingly. Therefore, it raises the question of what role the gut microbiota plays during helminth infection. Akkermansia muciniphila has emerged as a notable representative of beneficial microorganisms in the gut microbiota. Recent studies indicate that A. muciniphila is not merely associated with helminth infection but is also causally linked to infection. Here, we provide an overview of the crosstalk between A. muciniphila and enteric helminth infection. Our goal is to enhance our understanding of the interplay among A. muciniphila, helminths, and their hosts while also exploring the potential underlying mechanisms.


Assuntos
Akkermansia , Microbioma Gastrointestinal , Animais , Humanos , Helmintíase/imunologia , Helmintos/imunologia , Helmintos/genética , Verrucomicrobia/genética , Verrucomicrobia/imunologia
19.
Protein Expr Purif ; 219: 106483, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38609025

RESUMO

Mussel foot proteins (Mfps) possess unique binding properties to various surfaces due to the presence of L-3,4-dihydroxyphenylalanine (DOPA). Mytilus edulis foot protein-3 (Mefp-3) is one of several proteins in the byssal adhesive plaque. Its localization at the plaque-substrate interface approved that Mefp-3 plays a key role in adhesion. Therefore, the protein is suitable for the development of innovative bio-based binders. However, recombinant Mfp-3s are mainly purified from inclusion bodies under denaturing conditions. Here, we describe a robust and reproducible protocol for obtaining soluble and tag-free Mefp-3 using the SUMO-fusion technology. Additionally, a microbial tyrosinase from Verrucomicrobium spinosum was used for the in vitro hydroxylation of peptide-bound tyrosines in Mefp-3 for the first time. The highly hydroxylated Mefp-3, confirmed by MALDI-TOF-MS, exhibited excellent adhesive properties comparable to a commercial glue. These results demonstrate a concerted and simplified high yield production process for recombinant soluble and tag-free Mfp3-based proteins with on demand DOPA modification.


Assuntos
Di-Hidroxifenilalanina , Mytilus edulis , Animais , Di-Hidroxifenilalanina/química , Di-Hidroxifenilalanina/metabolismo , Mytilus edulis/genética , Mytilus edulis/química , Mytilus edulis/metabolismo , Proteínas Recombinantes/genética , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/isolamento & purificação , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Verrucomicrobia/genética , Verrucomicrobia/metabolismo , Monofenol Mono-Oxigenase/genética , Monofenol Mono-Oxigenase/metabolismo , Monofenol Mono-Oxigenase/química , Proteínas/genética , Proteínas/química , Proteínas/isolamento & purificação , Hidroxilação , Escherichia coli/genética , Escherichia coli/metabolismo
20.
Cell ; 187(11): 2717-2734.e33, 2024 May 23.
Artigo em Inglês | MEDLINE | ID: mdl-38653239

RESUMO

The gut microbiota has been found to play an important role in the progression of metabolic dysfunction-associated steatohepatitis (MASH), but the mechanisms have not been established. Here, by developing a click-chemistry-based enrichment strategy, we identified several microbial-derived bile acids, including the previously uncharacterized 3-succinylated cholic acid (3-sucCA), which is negatively correlated with liver damage in patients with liver-tissue-biopsy-proven metabolic dysfunction-associated fatty liver disease (MAFLD). By screening human bacterial isolates, we identified Bacteroides uniformis strains as effective producers of 3-sucCA both in vitro and in vivo. By activity-based protein purification and identification, we identified an enzyme annotated as ß-lactamase in B. uniformis responsible for 3-sucCA biosynthesis. Furthermore, we found that 3-sucCA is a lumen-restricted metabolite and alleviates MASH by promoting the growth of Akkermansia muciniphila. Together, our data offer new insights into the gut microbiota-liver axis that may be leveraged to augment the management of MASH.


Assuntos
Akkermansia , Bacteroides , Ácidos e Sais Biliares , Microbioma Gastrointestinal , Hepatopatia Gordurosa não Alcoólica , Simbiose , Animais , Humanos , Masculino , Camundongos , Akkermansia/metabolismo , Bacteroides/metabolismo , beta-Lactamases/metabolismo , Ácidos e Sais Biliares/metabolismo , Vias Biossintéticas/genética , Fígado Gorduroso/metabolismo , Fígado/metabolismo , Camundongos Endogâmicos C57BL , Verrucomicrobia/metabolismo , Hepatopatia Gordurosa não Alcoólica/metabolismo , Hepatopatia Gordurosa não Alcoólica/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA